Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1638759-79-1

Post Buying Request

1638759-79-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1638759-79-1 Usage

General Description

Methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate is a chemical compound with the molecular formula C10H9BrN2O2. It is an indazole derivative, which is a class of nitrogen-containing organic compounds. This particular compound contains a bromine atom, a methyl group, and a carboxylic ester group, which make it useful for various applications in organic synthesis and medicinal chemistry. Its structure and properties make it a potential candidate for pharmaceutical and agrochemical research, as well as for the development of new materials with specific properties. Further research on this compound could lead to its potential application in the development of new drugs or materials.

Check Digit Verification of cas no

The CAS Registry Mumber 1638759-79-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,3,8,7,5 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1638759-79:
(9*1)+(8*6)+(7*3)+(6*8)+(5*7)+(4*5)+(3*9)+(2*7)+(1*9)=231
231 % 10 = 1
So 1638759-79-1 is a valid CAS Registry Number.

1638759-79-1Downstream Products

1638759-79-1Relevant articles and documents

SUBSTITUTED HETEROCYCLIC AMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

-

Paragraph 0205-0206, (2022/02/02)

Provided are a substituted heterocyclic amide compound having a selective inhibitory effect on RIPK1, and a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug thereof, and a pharmaceutical composition containing the compound, and the

SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE

-

, (2019/01/21)

The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell pr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1638759-79-1